Immunogenicity and Safety of a Monovalent Glycoprotein-Conjugated (Diptheria Toxin -CRM197) Hib Vaccine in 13-59 Months Old Healthy Children

NCT01125527 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

700

Enrollment

INDUSTRY

Sponsor class

Conditions

Haemophilus Influenzae Type b (Hib) Infection

Interventions

BIOLOGICAL: Monovalent glyco-conjugated vaccine against Haemophilus influenzae type b (Hib)
BIOLOGICAL: Tetanus toxoid polysaccharide-conjugated vaccine against Haemophilus influenzae type b (Hib)

Sponsor

Novartis Vaccines